SLC7A11 and cancer: Suppressing the activity of SLC7A11 via genetic ablation or pharmacologic inhibition affects GSH synthesis, which leads to the accumulation of lipid peroxidation products, ultimately inducing ferroptosis in cancer cells.5, 6, 7, 8, 11